GB1279214A - Long-acting oral carrier - Google Patents
Long-acting oral carrierInfo
- Publication number
- GB1279214A GB1279214A GB174471A GB174471A GB1279214A GB 1279214 A GB1279214 A GB 1279214A GB 174471 A GB174471 A GB 174471A GB 174471 A GB174471 A GB 174471A GB 1279214 A GB1279214 A GB 1279214A
- Authority
- GB
- United Kingdom
- Prior art keywords
- weight
- carrier
- jan
- long
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
1279214 Sustained release compositions FOREST LABORATORIES INC 13 Jan 1971 [22 Jan 1970] 1744/71 Addition to 1171691 Heading A5B A pharmaceutical form for sustained buccal or sublingual administration consists of a shaped compressed product comprising a carrier of 100% to 80% by weight hydroxypropylmethyl cellulose and 0% to 20% by weight ethyl cellulose together with a therapeutically active ingredient, compressed at a pressure of 5 to 8 lbs./sq. inch in the presence of sufficient moisture as to provide the carrier with 5% to 25% by weight of water as dispersed moisture. The rate and duration of release of the active agent, which is either locally absorbed or swallowed in the saliva, is controlled by the size and shape of the product, and by the relative proportions of the two cellulose derivatives.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US514070A | 1970-01-22 | 1970-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1279214A true GB1279214A (en) | 1972-06-28 |
Family
ID=21714381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB174471A Expired GB1279214A (en) | 1970-01-22 | 1971-01-13 | Long-acting oral carrier |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1279214A (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2190409A1 (en) * | 1972-06-26 | 1974-02-01 | Lowey Hans | |
US4122157A (en) | 1977-03-04 | 1978-10-24 | Richardson-Merrell Inc. | Nitrofurantoin sustained release tablet |
FR2459049A1 (en) * | 1979-06-14 | 1981-01-09 | Forest Laboratories | PROCESS FOR THE PRODUCTION OF SHAPE PIECES FROM POWDERS CONSISTING OF SPHEROIDAL METAL PARTICLES |
EP0023359A2 (en) * | 1979-07-31 | 1981-02-04 | Teijin Limited | Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof |
US4292300A (en) | 1976-07-23 | 1981-09-29 | Inveresk Research International | Controlled release suppositories |
US4357469A (en) | 1979-06-14 | 1982-11-02 | Forest Laboratories, Inc. | Carrier base material for prolonged release therapeutic compositions |
US4680323A (en) * | 1983-12-01 | 1987-07-14 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
US4775535A (en) * | 1986-04-04 | 1988-10-04 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
FR2619717A1 (en) * | 1987-09-02 | 1989-03-03 | Medibrevex | NEW GALENIC FORMS OF INSULIN FOR PER- AND SUBLINGUAL DELIVERY |
US4855143A (en) * | 1986-04-04 | 1989-08-08 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
GB2219206A (en) * | 1988-02-03 | 1989-12-06 | Ddsa Pharmaceuticals Ltd | Sustained release medicinal formulations containing cellulose ethers |
US5098691A (en) * | 1991-05-06 | 1992-03-24 | Colgate-Palmolive Company | Composition for disclosing dental plaque |
US5190743A (en) * | 1991-05-06 | 1993-03-02 | Colgate-Palmolive Company | Composition for disclosing dental plaque |
WO1999040898A2 (en) * | 1998-02-12 | 1999-08-19 | Centrapharm Inc. | Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
WO2001045678A2 (en) * | 1999-12-21 | 2001-06-28 | Id Pharma Gmbh | Medicament, a method for its production and the use thereof |
-
1971
- 1971-01-13 GB GB174471A patent/GB1279214A/en not_active Expired
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2190409A1 (en) * | 1972-06-26 | 1974-02-01 | Lowey Hans | |
US4292300A (en) | 1976-07-23 | 1981-09-29 | Inveresk Research International | Controlled release suppositories |
US4122157A (en) | 1977-03-04 | 1978-10-24 | Richardson-Merrell Inc. | Nitrofurantoin sustained release tablet |
FR2459049A1 (en) * | 1979-06-14 | 1981-01-09 | Forest Laboratories | PROCESS FOR THE PRODUCTION OF SHAPE PIECES FROM POWDERS CONSISTING OF SPHEROIDAL METAL PARTICLES |
US4357469A (en) | 1979-06-14 | 1982-11-02 | Forest Laboratories, Inc. | Carrier base material for prolonged release therapeutic compositions |
EP0023359A2 (en) * | 1979-07-31 | 1981-02-04 | Teijin Limited | Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof |
EP0023359A3 (en) * | 1979-07-31 | 1981-11-04 | Teijin Limited | Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof |
US4680323A (en) * | 1983-12-01 | 1987-07-14 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
US4775535A (en) * | 1986-04-04 | 1988-10-04 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
US4855143A (en) * | 1986-04-04 | 1989-08-08 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
FR2619717A1 (en) * | 1987-09-02 | 1989-03-03 | Medibrevex | NEW GALENIC FORMS OF INSULIN FOR PER- AND SUBLINGUAL DELIVERY |
EP0306421A1 (en) * | 1987-09-02 | 1989-03-08 | Medibrevex Sa | Galenical insulin forms for per- and sublingual administration |
GB2219206A (en) * | 1988-02-03 | 1989-12-06 | Ddsa Pharmaceuticals Ltd | Sustained release medicinal formulations containing cellulose ethers |
US5098691A (en) * | 1991-05-06 | 1992-03-24 | Colgate-Palmolive Company | Composition for disclosing dental plaque |
US5190743A (en) * | 1991-05-06 | 1993-03-02 | Colgate-Palmolive Company | Composition for disclosing dental plaque |
WO1999040898A2 (en) * | 1998-02-12 | 1999-08-19 | Centrapharm Inc. | Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
WO1999040898A3 (en) * | 1998-02-12 | 1999-11-04 | Centrapharm Inc | Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
WO2001045678A2 (en) * | 1999-12-21 | 2001-06-28 | Id Pharma Gmbh | Medicament, a method for its production and the use thereof |
WO2001045678A3 (en) * | 1999-12-21 | 2002-04-11 | Id Pharma Gmbh | Medicament, a method for its production and the use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1171691A (en) | Lond-Acting Oral Carrier | |
GB1279214A (en) | Long-acting oral carrier | |
GB1405088A (en) | Slow release formulation | |
ES430431A1 (en) | Direct compression tabletting composition and pharmaceutical tablets produced therefrom | |
ES8402155A1 (en) | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose | |
ES8308698A1 (en) | Topical pharmaceutical compositions | |
GB1430684A (en) | Prolonged release lozenges | |
HUP0105463A2 (en) | Controlled release formulation of divalproex sodium | |
GB1465347A (en) | Composition | |
NZ337418A (en) | Paracetamol composition with improved rate of absorption | |
MY102728A (en) | Improvemant in and relating to effervescent acetlysalicylic acid tablets | |
GB1380171A (en) | Medicinal tablets | |
GB934089A (en) | Improvements in or relating to sustained release medicaments | |
GB1464200A (en) | Pharmaceutical composition | |
GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
IE41922L (en) | Pharmaceutical compositions containing bischromones | |
GB1202148A (en) | Pharmaceutical compositions | |
ATE204474T1 (en) | MEDICINAL PRODUCTS CONTAINING AMETHOCAIN | |
ES436179A1 (en) | Physiological substances for intensifying the pharmacological effect of drugs | |
GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
GB1351437A (en) | N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity | |
GB1327560A (en) | Effervescent pharmaceutical preparations | |
GB1292496A (en) | Dosage units of contraceptive preparations for human use | |
JPS5344617A (en) | Drug composition | |
ES372134A1 (en) | Novel pyridine derivatives, compositions containing the same, and methods of preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PE | Patent expired |